Moodys (MCO) (MLNX) (FTNT) (IPCM) (ISIL) Price Targets Raised

Price targets on Moodys Corporation (NYSE: MCO), Mellanox Technologies, Ltd. (NASDAQ: MLNX), Fortinet, Inc. (NASDAQ: FTNT), IPC The Hospitalist (NASDAQ: IPCM) and Intersil Corp. (NASDAQ: ISIL) raised by analysts.

The Benchmark Company raised their price target on Moodys Corporation (NYSE: MCO) from $38.00 to $43.00. They have a “buy” rating on the company.

JPMorgan Chase & Co. (NYSE:JPM) raised their price target on Mellanox Technologies, Ltd. (MLNX) from $29.00 to $31.00.

Deutsche Bank (NYSE:DB) raised their price target on Fortinet, Inc. (FTNT) from $40.00 to $44.00.

RBC Capital raised their price target on IPC The Hospitalist (IPCM) from $44.00 to $50.00. They have a “sector perform” rating on the company.

Longbow Research raised their price target on Intersil Corp. (ISIL) from $15.00 to $18.00. They have a “buy” rating on the company.

Infospace (INSP) (IPCM) (EQIX) (ISIL) (ITRI) Price Targets Adjusted

Price targets on Infospace Inc (NASDAQ: INSP), IPC The Hospitalist (NASDAQ: IPCM), Equinix, Inc. (NASDAQ: EQIX), Intersil Corp. (NASDAQ: ISIL) and Itron, Inc. (NASDAQ: ITRI) adjusted by analysts.

Benchmark Co. raised their price target on Infospace Inc (INSP) from $10.00 to $11.00. They have a “buy” rating on the company.

Jefferies (NYSE:JEF) raised their price target on IPC The Hospitalist (IPCM) from $58.00 to $60.00. They have a “buy” rating on the company.

Piper Jaffray raised their price target on Equinix, Inc. (EQIX) from $112.00 to $115.00. They have an “overweight” rating on the company.

Deutsche Bank (NYSE:DB) raised their price target on Intersil Corp. (ISIL) from $16.00 to $17.00.

Piper Jaffray cut their price target on Itron, Inc. (ITRI) from $65.00 to $63.00. They have a “neutral” rating on the company.

IPC The Hospitalist Company (NASDAQ:IPCM) Shares Should Appreciate in 2011

The market has overall liked IPC The Hospitalist Company (NASDAQ:IPCM) over the last several months, and their acquisition of Hospital Inpatient Management Services (HIMS) has added another feather in their cap.

Dougherty noted, "IPCM announced that it has acquired Midwest Hospital Specialists PA, Midwest Hospital Care LLC, and Peterson Management Co. (PMC), collectively known as Hospital Inpatient Management Services (HIMS)...We continue to expect IPCM shares to appreciate solidly going forward. As a result of this acquisition, continued strong execution of their core business and our revised outlook for 2011, we are raising our price target..."

Dougherty & Co keeps their "Buy" rating on IPC The Hospitalist Company, which closed Thursday at $39.58, gaining $0.87, or 2.25 percent. They raised their price target on IPC from $42 to $45.

IPC The Hospitalist Company's (NASDAQ:IPCM) HIMS Acquisition Pure Upside in 2011

Saying the size and timing of the acquisition of HIMS by IPC The Hospitalist Company (NASDAQ:IPCM) positions them for "pure" upside for their EPS estimate, Kaufman raised it, while added they've secured growth in 2011 from a range of 25 percent to 30 percent.

Kaufman noted, "We now look for 2011E EPS growth of 27%. Similar to the SCOC transaction (announced on 12/1/10), based on the size and the timing so late in 2010, the HIMS acquisition represents virtually "pure" upside to our 2011E EPS expectation, where we pre-layered $20M in acquisition spend throughout the year that we still expect to occur. As a result, we are raising our 2011E EPS by $0.05 to $1.83. In our view, IPC has secured its 2011 growth in the 25%-30% range with the flurry of acquisition activity in 4Q10, and while we think it is prudent to maintain a PEG discount based on the DOJ investigation, we are comfortable with a multiple in line with its current earnings growth rate (i.e., 2010 in the 23%-24% range)."

Kaufman Bros. maintains a "Buy" rating on IPC The Hospitalist Company, which closed Wednesday at $38.65, gaining $0.45, or 1.18 percent. Kaufman raised their price target on them from $36 to $43.

IPC The Hospitalist Company (NASDAQ:IPCM) Roaring on Acquisition Pipeline

IPC The Hospitalist Company (NASDAQ:IPCM) share price has been hot, and Jefferies believes that will continue as acquisitions and organic growth continue to grow the company.

Jefferies stated, "IPCM's acute and post-acute acquisition pipeline is red hot and will likely provide the company with incremental growth opportunities above and beyond what it is capturing today organically."

For full year 2011, EPS estimate was raised from $1.73 to $1.80, while revenue for full year 2010 was raised from $360.7 million to $361.1 million and for 2011 from $417.7 million to $436.3 million.

Jefferies maintains their "Buy" rating on IPC, which closed Thursday at $34.77, rising by $0.65, or 1.91 percent. They raised their price target on them from $39 to $41.